BC
INSM icon

Broadfin Capital’s Insmed INSM Stock Holding History

Broadfin Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-165,145
Closed -$2.58M – 65
2013
Q3 		$2.58M Sell
165,145
-126,595
-43% -$1.61M 0.46% 45
2013
Q2 		$3.49M Buy
+291,740
New +$2.98M 0.68% 33

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Broadfin Capital's INSM Position: Q4 2013 in Review

Broadfin Capital sold out of Insmed (INSM) in Q4 2013, closing a stake of 165,145 shares — an estimated $2.58M sold.

Broadfin Capital first reported a position in INSM in Q2 2013 and held it in 2 quarters. The position peaked at $3.49M in Q2 2013. 89 funds tracked by Wall St. Rank hold INSM as of Q4 2013.

  • Broadfin Capital reported no remaining Insmed position as of Q4 2013 after selling out during the quarter.
  • Broadfin Capital sold 165,145 Insmed shares in Q4 2013, an estimated $2.58M.
  • Broadfin Capital first reported a position in Insmed in Q2 2013 and held it in 2 quarters.
  • Broadfin Capital's Insmed position peaked at $3.49M in Q2 2013.
  • 89 funds tracked by Wall St. Rank held Insmed as of Q4 2013.

Based on Broadfin Capital's 13F filing for Q4 2013, filed 14 Feb 2014.